NCT07525674 Vacuum Sealing Drainage (VSD) in Promoting Wound Healing and Reducing Complications in Post-Infected Obstetric and Gynecological Surgical Sites
| NCT ID | NCT07525674 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Minia University |
| Condition | Wound Heal |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-04-20 |
| Primary Completion | 2027-01-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-04-20 with a primary completion date of 2027-01-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the efficacy of VSD in promoting wound healing and reducing complications, such as re-infection, prolonged hospitalization, and need for further surgical interventions, in obstetric and gynecological patients who have developed surgical site infections following their primary procedures. The investigators hypothesize that VSD will lead to faster wound healing, fewer complications, and improved patient outcomes compared to conventional wound care in this specific patient population.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of a surgical site infection (SSI) following an obstetric or gynecological surgical procedure (e.g., Cesarean section, hysterectomy, myomectomy, salpingo-oophorectomy). * Wound classification as superficial incisional SSI, deep incisional SSI, or organ/space SSI (if accessible for VSD application). * Willingness and ability to provide informed consent. * Wound requiring secondary intention healing or delayed primary closure after debridement Exclusion Criteria: * Patients with necrotic tissue. * Presence of exposed blood vessels, organs, or anastomotic sites where VSD is contraindicated. * Untreated coagulopathy or active bleeding diathesis. * Allergy to VSD components or dressing materials. * Patients with significant immunosuppression (e.g., uncontrolled HIV, organ transplant recipients on high-dose immunosuppressants). * Patients with malignant wounds. * Patients who decline participation. * Patients requiring immediate primary wound closure without debridement. * Patients with a known history of severe psychiatric illness affecting compliance.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07525674 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 70 Years, studying Wound Heal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07525674 currently recruiting?
Yes, NCT07525674 is actively recruiting participants. Contact the research team at mohamedeleboany@gmail.com for enrollment information.
Where is the NCT07525674 trial being conducted?
This trial is being conducted at Minya, Egypt.
Who is sponsoring the NCT07525674 clinical trial?
NCT07525674 is sponsored by Minia University. The trial plans to enroll 60 participants.